SEOM clinical guidelines for the adjuvant treatment of colorectal cancer

被引：0

作者：

Cristina Grávalos Castro

Joan Maurel Santasusana

Fernando Rivera Herrero

Ramón Salazar Soler

Isabel Sevilla García

Javier Sastre Valera

José M. Tabernero Caturla

Encarnación González Flores

María Lomas Garrido

Dolores Isla Casado

机构：

[1] 12 de Octubre University Hospital,Medical Oncology Department

[2] Hospital Clínic i Provincial,Servicio de Oncología Médica

[3] Hospital Universitario Marqués de Valdecilla,Servicio de Oncología Médica

[4] Hospital Durán i Reynals — Instituto Catalán de Oncología (ICO) L’Hospitalet de Llobregat,Servicio de Oncología Médica

[5] Hospital Clínico Universitario Virgen de la Victoria,Servicio de Oncología Médica

[6] Hospital Clínico Universitario San Carlos,Servicio de Oncología Médica

[7] Hospital General Universitario Vall d’Hebrón,Servicio de Oncología Médica

[8] Hospital Universitario Virgen de las Nieves,Servicio de Oncología Médica

[9] Hospital Médico Quirúrgico,Servicio de Oncología Médica

[10] Hospital Clínico Universitario Lozano Blesa,Servicio de Oncología Médica

[11] Hospital Universitario 12 de Octubre,Servicio de Oncología Médica

来源：

Clinical and Translational Oncology | 2010年 / 12卷

关键词：

Colorectal cancer; Diagnosis; Treatment; Guidelines; SEOM;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Colorectal cancer is the third most common malignant neoplasm and the second cause of death by cancer in western countries. In this manuscript, the clinical guidelines of the Spanish Society of Medical Oncology (SEOM) for diagnosis and adjuvant treatment of colon cancer and rectal cancer are reported.

引用

页码：724 / 728

页数：4

共 63 条

[11]

Veldkamp R.(2009)A phase III trial comparing FOLFOX6 to mFOLFOX6 plus bevacizumab in stage II or III carcinoma of the colon: results of NSABP Protocol C-08 J Clin Oncol 27 LBA4-646

[12]

Hop W.C.(2004)American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer J Clin Oncol 22 3408-4386

[13]

André T.(2001)Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med 345 638-1740

[14]

Boni C.(2007)Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group J Clin Oncol 25 4379-1123

[15]

Navarro M.(2004)Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731-865

[16]

Wolmark N.(2006)Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 1114-1871

[17]

Wieand S.(2009)Randomized multicenter phase III trial comparing two neoadjuvant chemoradiotherapy (CT-RT) regimens (RT45-Cap versus RT50-Capox) in patients with locally advanced rectal cancer (LARC): results of the ACCORD 12/0405 PRODIGE 2 J Clin Oncol 27 LBA 4007-undefined

[18]

Kueber J.P.(2009)Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: pathologic response analysis of the Studio Terapia Adiuvante Retto (STAR)-01 randomized phase III trial J Clin Oncol 27 CRA4008-undefined

[19]

Lembersky B.C.(2010)Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo Cáncer de Recto 3 Study J Clin Oncol 28 859-undefined

[20]

Wieand S.(2007)Follow-up strategies for patients treated for non-metastatic colorectal cancer Cochrane Database Syst Rev 1 CD002200-undefined

← 1 2 3 4 5 6 7 →